ADMT ADM TRONICS UNLIMITED, INC.
Electromedical & Electrotherapeutic Apparatus · OTC · SEC CIK 849401 · Fiscal year ends 03/31
Financial factors as of 2026-09-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-2.0%
TTM net income YoY-8.3%
TTM EPS YoY—
Revenue 3-yr CAGR1.7%
Net income 3-yr CAGR—
Margins
Gross margin42.6%
Operating margin-4.4%
Net margin-4.3%
FCF margin—
EBITDA margin-4.2%
Returns
ROE-17.3%
ROA-6.7%
ROIC (approx.)-20.8%
Asset turnover1.57x
Leverage & solvency
Liabilities / assets63.6%
Debt / equity0.00x
Current ratio1.08x
Interest coverage-4.10x
Cash quality & payout
Operating cash flow / net income0.80x
Accruals ratio-1.3%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-03-31 | FY20252025-03-31 |
|---|---|---|
| Income statement | ||
| Revenue | $3.35M | $3.20M |
| Cost of revenue | $1.99M | $1.80M |
| Gross profit | $1.36M | $1.40M |
| R&D expense | $544,971 | $517,275 |
| SG&A expense | $969,550 | $972,409 |
| Operating income | -$159,097 | -$94,024 |
| Interest expense | $36,788 | $40,210 |
| Pretax income | -$98,874 | -$121,556 |
| Income tax | $1,500 | $1,500 |
| Net income | -$100,374 | -$123,056 |
| EBITDA | -$152,280 | -$86,718 |
| EPS (basic) | 0.00 | 0.00 |
| EPS (diluted) | 0.00 | 0.00 |
| Banking | ||
| Provision for credit losses | — | $0 |
| Balance sheet | ||
| Cash & equivalents | $255,730 | $382,969 |
| Receivables | $515,660 | $528,383 |
| Inventory | $250,624 | $336,270 |
| Current assets | $1.02M | $1.25M |
| Intangibles | $8,250 | $15,067 |
| Total assets | $1.83M | $2.13M |
| Current liabilities | $1.05M | $1.15M |
| Total liabilities | $1.26M | $1.46M |
| Shareholders' equity | $570,972 | $671,346 |
| Shares outstanding | 67.59M | 67.59M |
| Cash flow statement | ||
| Operating cash flow | -$124,059 | $9,978 |
| Investing cash flow | $0 | -$225,750 |
| Financing cash flow | -$3,180 | $61,700 |
| Depreciation & amortization | $6,817 | $7,306 |
| Stock-based compensation | $0 | $4,128 |
Free plan shows the latest 2 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.